Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

I Díez de Corcuera, JL Manzano… - Clinical and …, 2017 - Springer
Purpose In the VELOUR study, aflibercept+ FOLFIRI regimen resulted in improved survival
in metastatic colorectal cancer (mCRC) patients who progressed after oxaliplatin. The use of …
被引用次数：16 相关文章

Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain.

J Feliu, I Díez de Corcuera, JL Manzano… - … : Official Publication of …, 2016 - europepmc.org
Purpose In the VELOUR study, aflibercept+ FOLFIRI regimen resulted in improved survival
in metastatic colorectal cancer (mCRC) patients who progressed after oxaliplatin. The use of …

Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

J Feliu, I Díez de Corcuera, JL Manzano… - 2017 - digital.csic.es
[Results] Registries from 71 mCRC patients included in the NPP were reviewed
retrospectively. The median age for the NPP population was 64 years (19.7% aged≥ 70 …

[引用][C] Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

J Feliu, I Díez de Corcuera… - Clinical and …, 2017 - produccioncientifica.ucm.es

Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain.

J Feliu, I Díez de Corcuera, J Manzano… - Clinical & …, 2017 - search.ebscohost.com
Purpose: In the VELOUR study, aflibercept+ FOLFIRI regimen resulted in improved survival
in metastatic colorectal cancer (mCRC) patients who progressed after oxaliplatin. The use of …

Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

J Feliu, I Díez de Corcuera, JL Manzano… - Clin. transl. oncol …, 2017 - pesquisa.bvsalud.org
Purpose. In the VELOUR study, aflibercept+ FOLFIRI regimen resulted in improved survival
in metastatic colorectal cancer (mCRC) patients who progressed after oxaliplatin. The use of …
[PDF] researchgate.net

[PDF][PDF] Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

J Feliu, ID de Corcuera, JL Manzano… - 2016 - researchgate.net
Purpose In the VELOUR study, aflibercept? FOLFIRI regimen resulted in improved survival
in metastatic colorectal cancer (mCRC) patients who progressed after oxaliplatin. The use of …

Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

J Feliu, ID de Corcuera, JL Manzano… - Clinical and …, 2016 - infona.pl
Purpose In the VELOUR study, aflibercept+ FOLFIRI regimen resulted in improved survival
in metastatic colorectal cancer (mCRC) patients who progressed after oxaliplatin. The use of …

Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

JF Batlle, ID de Corcuera Frutos… - Clinical & …, 2017 - dialnet.unirioja.es
Purpose In the VELOUR study, aflibercept+ FOLFIRI regimen resulted in improved survival
in metastatic colorectal cancer (mCRC) patients who progressed after oxaliplatin. The use of …

Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

J Feliu, ID de Corcuera, JL Manzano… - … publication of the …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose In the VELOUR study, aflibercept+ FOLFIRI regimen resulted in improved survival
in metastatic colorectal cancer (mCRC) patients who progressed after oxaliplatin. The use of …